QUODD

Insider Transactions last 24 months for Avenue Therapeutics, Inc. - OTC: ATXI

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Fortress Biotech, Inc.	Other	03/31/2025	AA	Direct	COM	33,724	$0.00	$0.00	328,524
Herskowitz Neil	Director	12/02/2024	DS	Direct	COM	23	$2.00	$46.00	97
Kranzler Jay D	Director	11/05/2024	DS	Direct	COM	61	$2.24	$136.64	559
Jin David	Interim PFO and COO	09/23/2024	AA	Direct	COM	65,000	$0.00	$0.00	65,000
Maclean Alexandra	Chief Executive Officer	09/23/2024	AA	Direct	COM	170,000	$0.00	$0.00	170,000
Fortress Biotech, Inc.	Other	04/16/2024	AA	Direct	COM	413,507	$0.00	$0.00	3,547,393
Davidow Robert L	Other	12/11/2023	DS	Indirect	COM	20,000	$0.14	$2,800.00	80,000
Davidow Robert L	Other	12/11/2023	DS	Indirect	COM	128,000	$0.14	$17,920.00	147,000
Davidow Robert L	Other	12/11/2023	DS	Indirect	COM	126,000	$0.14	$17,640.00	215,800
Davidow Robert L	Other	12/11/2023	DS	Indirect	COM	61,000	$0.14	$8,540.00	74,000
Davidow Robert L	Other	12/11/2023	DS	Indirect	COM	18,000	$0.15	$2,700.00	22,000
Davidow Robert L	Other	12/11/2023	DS	Direct	COM	264,000	$0.14	$36,960.00	681,000

1 You are at page 1 of 1 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel